NEWBIOGEN – New Generation of orthopaedic Biomaterials
NewBioGen introduces a new biomaterial production process that will solve the current problems and provide a new generation of orthopaedic bio-implants
NewBioGen introduces a new biomaterial production process that will solve the current problems and provide a new generation of orthopaedic bio-implants. Beta titanium alloys, containing fully biocompatible elements, will be optimised and validated as raw materials for the biomaterial production. The new production process will be using powder metallurgy technology. Use of powder metallurgy for bio-implants production will allow increased control of the final characteristics and properties of the product. It is expected to significantly reduce the chemical and porous inhomogeneties – a source of stress and cause of mechanical implant failure. The next step in our novel approach is the application of ZrO2/Zr coating on the implant using Laser Engineered Net Shape techniques to give better wear resistance and lower the possibility of interfacial separation under repeated loading condition. NewBioGen is taking a new route to establish methods that yield high precision and quality biomaterials and will validate their increased biocompatibility, wear resistance, corrosion resistance, enhanced mechanical and tribological properties.
CyRIC has been responsible for the design and development of the mixing and packing machinery.